Monthly Archives: February 2012

Researchers have shot another arrow through the credibility of claims that a virus likely causes chronic fatigue syndrome (CFS). This time, results from nine different labs around the United States failed to differentiate patients with CFS from healthy controls solely … Continue reading →

Kalydeco, the first drug that targets the defective protein behind a rare form of the deadly lung disorder cystic fibrosis, was approved Tuesday by the U.S. Food and Drug Administration. One patient advocate group applauded the decision. “Today marks an … Continue reading →

Treating stroke patients with stem cells taken from their own bone marrow appears to safely help them regain some of their lost abilities, two small new studies suggest. Indian researchers observed mixed results in the extent of stroke patients’ improvements, … Continue reading →